Long-term outcomes at 5 years post-transplant in imlifidase-desensitized kidney transplant patients.

Autor: Jordan SC; Cedars-Sinai Medical Center, Comprehensive Transplant Center, Los Angeles, California, USA., Maldonado AQ; Hansa Biopharma AB, Lund, SWEDEN. Electronic address: angela.maldonado@hansabiopharma.com., Lonze BE; NYU Langone Transplant Institute, New York, New York, USA., Sjöholm K; Hansa Biopharma AB, Lund, SWEDEN., Lagergren A; Hansa Biopharma AB, Lund, SWEDEN., Montgomery RA; NYU Langone Transplant Institute, New York, New York, USA., Runström A; Hansa Biopharma AB, Lund, SWEDEN., Desai NM; Northwell Transplant Institute, Manhassett, New York, USA., Legendre C; Hôpital Necker & Université Paris Cité, Paris, FRANCE., Lundgren T; Karolinska Institutet, Department of Transplantation Surgery, Stockholm, SWEDEN., von Zur Mühlen B; Uppsala University, Department of Surgical Sciences, Uppsala, SWEDEN., Vo AA; Cedars-Sinai Medical Center, Comprehensive Transplant Center, Los Angeles, California, USA., Tollemar J; Hansa Biopharma AB, Lund, SWEDEN., Lefèvre P; Hansa Biopharma AB, Lund, SWEDEN., Lorant T; Uppsala University, Department of Surgical Sciences, Uppsala, SWEDEN.

Publikováno v: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2024 Dec 04. Date of Electronic Publication: 2024 Dec 04.

Efficacy of Sotrastaurin Plus Tacrolimus After De Novo Kidney Transplantation: Randomized, Phase II Trial Results

Autor: Russ, G.R. ^*, Tedesco-Silva, H., Kuypers, D.R., Cohney, S., Langer, R.M., Witzke, O., Eris, J., Sommerer, C., von Zur-Mühlen, B., Woodle, E.S., Gill, J., Ng, J., Klupp, J., Chodoff, L., Budde, K.

Publikováno v: In American Journal of Transplantation July 2013 13(7):1746-1756

Long-term Prolonged-release Tacrolimus-based Immunosuppression in De Novo Kidney Transplant Recipients: 5-Y Prospective Follow-up of Patients in the ADVANCE Study.

Autor: Pernin V; Department of Nephrology, Dialysis and Transplantation, Hôpital Lapeyronie, University of Montpellier, Montpellier, France., Glyda M; Department of Transplantology and Surgery, District Public Hospital Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Bydgoszcz, Poland., Viklický O; Department of Nephrology, Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic., Lõhmus A; Department of Urology and Kidney Transplantation, Clinic of Surgery, Tartu University Hospital, Tartu, Estonia., Wennberg L; Department of Transplantation Surgery, Karolinska University Hospital, Stockholm, Sweden., Witzke O; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisberg-Essen, Germany., von Zur-Mühlen B; Department of Surgical Sciences, Division of Transplantation Surgery, Uppsala University Hospital, Uppsala, Sweden., Anaokar S; Medical Affairs, Astellas Pharma Europe, Chertsey, United Kingdom., Hurst M; Medical Affairs, Astellas Pharma Europe, Chertsey, United Kingdom., Kazeem G; Medical Affairs, Astellas Pharma Europe, Chertsey, United Kingdom.; BENKAZ Consulting Ltd, Cambridge, United Kingdom., Undre N; Medical Affairs, Astellas Pharma Europe, Chertsey, United Kingdom., Kuypers DRJ; Department of Nephrology and Renal Transplantation, University Hospitals Leuven, Leuven, Belgium.

Publikováno v: Transplantation direct [Transplant Direct] 2023 Feb 08; Vol. 9 (3), pp. e1432. Date of Electronic Publication: 2023 Feb 08 (Print Publication: 2023).

Outcomes at 3 years posttransplant in imlifidase-desensitized kidney transplant patients.

Autor: Kjellman C; Hansa Biopharma AB, Lund, Sweden., Maldonado AQ; Hansa Biopharma AB, Lund, Sweden., Sjöholm K; Hansa Biopharma AB, Lund, Sweden., Lonze BE; NYU Langone Transplant Institute, New York, New York, USA., Montgomery RA; NYU Langone Transplant Institute, New York, New York, USA., Runström A; Hansa Biopharma AB, Lund, Sweden., Lorant T; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden., Desai NM; Johns Hopkins University, Baltimore, Maryland, USA., Legendre C; Hôpital Necker & Paris Descartes University, Paris, France., Lundgren T; Department of Transplantation Surgery, Karolinska Institutet, Stockholm, Sweden., von Zur Mühlen B; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden., Vo AA; Cedars-Sinai Medical Center, Comprehensive Transplant Center, Los Angeles, California, USA., Olsson H; Hansa Biopharma AB, Lund, Sweden., Jordan SC; Cedars-Sinai Medical Center, Comprehensive Transplant Center, Los Angeles, California, USA.

Publikováno v: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2021 Dec; Vol. 21 (12), pp. 3907-3918. Date of Electronic Publication: 2021 Jul 19.

COVID-19 in solid organ transplant recipients: A national cohort study from Sweden.

Autor: Søfteland JM; The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Friman G; Department of Transplantation Surgery, Karolinska University Hospital, Stockholm, Sweden., von Zur-Mühlen B; Department of Transplantation Surgery, Uppsala University Hospital, Uppsala, Sweden., Ericzon BG; Department of Transplantation Surgery, Karolinska University Hospital, Stockholm, Sweden., Wallquist C; Department of Nephrology, Skåne University Hospital, Malmö, Sweden., Karason K; The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden., Friman V; Department of Infectious Diseases, Institute of Biomedicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Ekelund J; Centre of Registers, Västra Götaland, Gothenburg, Sweden., Felldin M; The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden., Magnusson J; The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden., Haugen Löfman I; Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden., Schult A; The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden., de Coursey E; The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden., Leach S; Department of Microbiology and Immunology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Clinical Pharmacology, Sahlgrenska University Hospital, Gothenburg, Sweden., Jacobsson H; The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden.; Biobank West, Sahlgrenska University Hospital, Gothenburg, Sweden., Liljeqvist JÅ; Department of Infectious Diseases, Institute of Biomedicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Biglarnia AR; Department of Transplantation Surgery, Skåne University Hospital, Malmö, Sweden., Lindnér P; The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Oltean M; The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Publikováno v: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2021 Aug; Vol. 21 (8), pp. 2762-2773. Date of Electronic Publication: 2021 May 06.